H-VWLSAIWM-OH

Rif. 3D-PP46532

Informazioni sul prodotto

• Nome: H-VWLSAIWM-OH
• Sinonimi: NH2-Val-Trp-Leu-Ser-Ala-Ile-Trp-Met-OH

Descrizione

Peptide H-VWLSAIWM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VWLSAIWM-OH include the following: Knockdown of virus antigen expression increases therapeutic vaccine efficacy in high-titer hepatitis B virus carrier mice T Michler , AD Kosinska, J Festag, T Bunse, J Su - Gastroenterology, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0016508520301256 PD-L1 silencing in liver using siRNAs enhances efficacy of therapeutic vaccination for chronic hepatitis b T Bunse, AD Kosinska, T Michler , U Protzer - Biomolecules, 2022 - mdpi.comhttps://www.mdpi.com/2218-273X/12/3/470 Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen R Schirmbeck, W Böhm, N Fissolo - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324125 Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance J Sacherl, AD Kosinska, K Kemter, M Kachele - JHEP Reports, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2589555922001756 Immunogenicity and antiviral response of therapeutic hepatitis B vaccination in a mouse model of HBeAg-negative, persistent HBV infection AD Kosinska, J Festag, M Muck-Hausl, MM Festag - Vaccines, 2021 - mdpi.comhttps://www.mdpi.com/2076-393X/9/8/841

• Marchio: Biosynth